Patent ID: 9114102
Filing Date: 2015-08-25
Classification: A61K,A61P

Abstract:
1. A method of enhancing the chemotherapeutic treatment of tumor in a mammal with a chemotherapeutic agent, which method comprises administering to the mammal an effective amount of the chemotherapeutic agent in conjunction with an effective amount of a compound to inhibit ABCG2 protein, said compound being NSC 168201: wherein the tumor is selected from prostate tumor, brain tumor, lymphoma, ovarian tumor, and stomach tumor; and wherein the chemotherapeutic agent is selected from flavopiridol, rhodamine, daunomycin, imatinib, doxorubicin, colchicine, vinblastine, paclitaxel, adriamycin, danofloxacin mesylate, docetaxel, and a combination thereof.